Login  /  Register  | 3 premium articles left before you must register.

Amarin plans new stock offering

Published July 11. 2013 4:00AM

Irish biotech Amarin Corp. plc, with R&D headquarters in Groton, has announced that it will sell 21.7 million of American Depository Shares during a public offering.

Amarin's share price immediately dropped 9 percent after the announcement. Shareholders apparently were concerned about the dilution of value for existing shares, according to the investor site TheMotleyFool.

In addition to the 21.7 million shares, underwriters will have an option to purchase another 3.2 million or so shares at prevailing prices.

The money will be used to continue Amarin's launch of heart drug Vascepa as well as to conduct studies to expand the pill's potential market.

News by Town

Most Recent Poll
If you had to give up 20 percent of your salary for the next 11 weeks, how would you get by?
I'd move my family in with my parents.
I'd give up all my luxuries: dining out, vacations and clothes shopping.
I don't think I'd notice. I don't know what the federal employees are complaining about.
I'm looking forward to an extra day off.
I'm worried about digging a bigger debt hole.
Number of votes: 1810

No current items found